A Scientific leader, innovator & expert in the Respiratory field. Driver of pre-competitive patient-focused international partnerships and collaborations.
Joined September 2015
- Tweets 900
- Following 153
- Followers 320
- Likes 2,741
115 Photos and videos
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Are you a patient or caregiver affected by bronchiectasis?
Come join the Association & Patient Programme at #WBConf26
Get helpful knowledge and insights - through Interactive sessions on self-care, real-life challenges, and emotional wellbeing.
π bit.ly/4tibfW1
ALT Are you a patient or caregiver affected by bronchiectasis? Come join the Association & Patient Programme at #WBConf26 Get helpful knowledge and insights - through Interactive sessions on self-care, real-life challenges, and emotional wellbeing. π https://bit.ly/4tibfW1
1
4
2
432
Looking forward to the conference!
Join us at the 9th World Bronchiectasis Conference on 24β26 June. We'll speak on Phase III trial co-designing, the Chronic Airways Assessment Test (CAAT)β’, and results from the GAAPP Multilingual Online Interactive Quiz, and more.
#WBConf26
30
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Tomorrow, on World #EoEDay, we're hosting a multidisciplinary webinar dedicated to advancing the global understanding of EoE. π 13:00 Central Europe Time
π REGISTER: eoeday.org/webinar
.
#FoodShouldNotHurt
1
1
35
Last day at the excellent conference #ATS2026 β¦ exciting time in Respiratory with a bright future of new #diagnostics, novel #endpoints, a growing interest in early interventions and lots of data shared by @gaapporg !
@COPDKristen
2
92
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Meet the new #AsthmaCareMap: A tool for concrete examples and evidence of asthma-based research. It compiles 1,937 research insights from 153 peer-reviewed publications, public health reports, and clinical guidelines into a single, organized resource.
π asthmacaremap.com
2
60
IIa there a potential for combining #CAAT and 5STS as simple tools for for evaluation of exercise tolerance in primary care? @AlanLHamilton
tandfonline.com/doi/full/10.β¦
22
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
#ICAN2026: Call for abstracts for early career researchers (5 September, Barcelona). Topics: Immune mechanisms and treatment response to AI, imaging, and novel therapies. Selected abstracts receive travel, accommodation support. Deadline extended: 22 May πican.gaapp.org
2
3
30
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
#ICAN2026: Call for abstracts for early career researchers (5 September, Barcelona). Topics: Immune mechanisms and treatment response to AI, imaging, and novel therapies. Selected abstracts receive travel support accommodation. Deadline: 15 April, 2026 πican.gaapp.org
2
2
36
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
1
2
4
54
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Both 10mg and 25mg brensocatib has been approved in the US for treatment of bronchiectasis.
In the absence of official guidance, Chuck Daley and i comment on optimal dosing, concluding that 25mg should be the preferred dose for patients
@ATSBlueEditor
academic.oup.com/ajrccm/advaβ¦
2
19
46
2,706
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Call for Abstracts for Early Career Researchers: share your work at ICAN 2026 (5 September, Barcelona). Join a collaborative community advancing respiratory research β from immune mechanisms and treatment response to AI, imaging, and novel therapies. Connect with peers and global experts across academia, industry, NIH, ERS, and more. Only 50 abstracts will be selected.
βοΈ Selected abstracts will receive travel support accommodation
π
Deadline: 15 April, 2026
π ican.gaapp.org
2
4
65
Congratulations to @gaapporg #CERT Governance Board members, patient advocates and GSK collaborators on our publication describing the translation, linguistic, and cross-cultural validation of the #COPD Exacerbation Recognition Tool.
doi.org/10.15326/jcopdf.2025β¦
34
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Mar 25
Check our new interactive learning module on bronchiectasis - talking about the new ERS guidelines and much more with Sanjay Chotirmall and Natalie Lorent β€οΈ
Mar 24
New Interactive Education: Unmasking bronchiectasis β From guidelines to the bedside: expert case reflections
Join the experts as they discuss the critical need for high-quality, case-based learning to help clinicians improve practice in bronchiectasis: channel.ersnet.org/media-121β¦
1
9
32
1,740
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Mar 21
What about the other pathogens i hear you say?
@alferes_de and @lifearc1 have you covered
Rapid rRNA detection of H. influenzae, S. aureus, S. pneumoniae and M. catarrhalis in bronchiectasis sputum. Better than culture- the future of micro is molecular!
publications.ersnet.org/contβ¦
Mar 21
New paper! Collaboration between @EMBARCnetwork and @lifearc1 shows a molecular test can sensitively and accurately detect and quantify Pseudomonas infection in bronchiectasis.
The BQA was better than culture
@alferes_de @beccahull_ @MereteLong @OSibila
publications.ersnet.org/contβ¦
1
5
15
1,511
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
Mar 15
Our latest paper just out in @LancetRespirMed
10 unanswered questions about DPP1 inhibition in bronchiectasis
We outline key future clinical and research questions after the approval of the first new therapy for people with bronchiectasis.
Congratulations Jiahui, Chloe and @MereteLong
3
21
52
2,692
R Tal-Singer Lung Health Researcher & Advocate π« retweeted
In celebration of International Womenβs Day, join us for the next #GAAPPAcademy webinar! 9 global experts share their journey with leadership and community impact as they discuss βThe Role of Women in Patient Advocacyβ.
π 9 March 2026 π 15:00 CET π Register: us06web.zoom.us/webinar/regiβ¦
2
4
57
π£ A big step for patient-centred, evidence-based respiratory care.
The #CAAT & #CERT tools β coordinated by Governance Boards at @gaapporg β are now included in the 2026 German National #COPD Guidelines π©πͺ
π lnkd.in/euG94-fj
#RespiratoryHealth #PatientCare
45
New publication π’
US survey (n=3,024) of adults with chronic conditions shows favorable attitudes toward flu/COVID vaccines & antivirals.
Risk perception strongly linked to uptake. sciencedirect.com/science/arβ¦
#Vaccines #PublicHealth #COPD #Asthma #diabetes
@gaapporg @COPDKristen
21
Take the quiz to find out how well you understand #bronchiectasis
Letβs talk about bronchiectasis!
This chronic lung disease affects people of all ages across the globeβbut itβs often
misunderstood.
Can it be treated? Is it contagious? Take our short quiz to learn the facts and feel more
informed.
Take the quiz here β‘οΈ gaapp.org/diseases/bronchiecβ¦
2
52